BDNF and depressive symptom measurement: In FST-induced depression in rats, paeoniflorin can alleviate both the hyperactivity of the HPA axis and oxidative damage, increase plasma and hippocampal monoamine neurotransmitters and brain-derived neurotrophic factor (BDNF) levels, and promote gastrointestinal movement [48].